Perrigo company plc (PRGO)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Jun'15Jun'14Jun'13Jun'12
Cash Flows From (For) Operating Activities
Net income

146,100

131,000

119,600

-4,012,800

136,100

232,800

441,900

401,600

Adjustments to derive cash flows:
Depreciation and amortization

396,500

423,600

444,800

457,000

258,700

206,100

160,200

135,300

Gain on sale of business

71,700

0

0

-

-

-

-

8,600

Loss on acquisition-related foreign currency derivatives

-

-

-

-

326,400

0

0

-

Share-based compensation

52,200

37,700

43,800

23,000

31,600

24,600

18,400

19,000

Impairment charges

184,500

224,400

47,500

2,631,000

6,800

6,000

0

-

Asset abandonments

-11,000

0

0

-

-

-

-

-

Change in financial assets

22,100

188,700

-24,900

-2,608,200

78,500

26,600

-

-

Loss on extinguishment of debt

-200

-500

-135,200

-1,100

-10,500

-165,800

0

0

Restructuring charges

26,300

21,000

61,000

31,000

5,100

47,000

2,900

8,700

Write-off of in-process research and development

-

-

-

-

-

-

-

0

Gain on sale of pipeline development projects

-

-

-

-

-

-

-

-3,500

Loss on Sale of Investments

-

-

-

-

-

-

-

0

Income tax benefit from exercise of stock options

-

-

-

-

-

-

-

-1,800

Excess tax benefit of stock transactions

-

-

-

-

-

-

-

12,900

Deferred income taxes

-43,900

-17,900

-48,900

-990,900

-16,300

-49,700

5,700

27,500

Amortization of debt premium

-4,400

-8,100

-22,400

-24,700

200

2,000

-

-

Other non-cash adjustments, net

26,600

-11,100

-2,700

33,500

10,200

4,500

-3,400

-

Subtotal

701,300

612,400

802,800

756,400

690,800

612,500

625,600

565,200

Increase (decrease) in cash due to:
Accounts receivable

140,700

-21,000

-3,200

600

51,100

140,500

37,000

49,300

Inventories

67,000

98,600

16,000

-100,700

11,400

-84,700

94,600

-5,400

Accounts payable

17,000

28,800

-39,600

-75,700

120,500

-24,900

6,500

-23,600

Payroll and related taxes

-3,700

-34,500

-27,400

-41,100

-30,200

-55,500

-11,900

5,000

Accrued customer programs

-48,600

25,500

34,600

-13,900

71,300

113,100

12,600

-1,600

Accrued liabilities

-23,200

-20,900

-47,800

-79,500

42,800

23,000

8,400

4,200

Accrued income taxes

-74,500

68,100

-6,100

20,900

21,900

-11,300

28,900

13,700

Other, net

-27,200

8,800

4,800

12,300

-600

-31,900

-15,300

5,700

Subtotal

313,500

19,400

103,900

101,500

-164,400

-20,500

71,800

51,800

Net cash from operating activities

387,800

593,000

698,900

654,900

855,200

633,000

553,800

513,400

Cash Flows From (For) Investing Activities
Proceeds from royalty rights

2,900

13,700

87,300

353,700

344,600

60,500

-

-

Acquisitions of businesses, net of cash acquired

747,700

0

400

427,400

2,177,800

1,605,800

852,300

582,300

Asset acquisitions

149,100

35,600

0

-

-

-

-

-

Payments to Acquire Intangible Assets

-

-

-

65,100

4,000

0

-

-

Purchase of investment securities

0

7,500

0

0

329,900

0

0

-

Proceeds from the Royalty Pharma contingent milestone

250,000

0

0

-

-

-

-

-

Payments to Acquire Available-for-sale Securities

-

-

-

-

-

-

-

0

Proceeds from Sale of Property, Plant, and Equipment

-

-

-

-

-

-

-

0

Proceeds from sale of intangible assets and pipeline development projects

-

-

-

-

-

-

-

10,500

Asset acquisitions

-

-

-

-

-

-

-

800

Proceeds from sale of securities

-

-

-

4,500

0

81,400

8,600

0

Additions to property, plant and equipment

137,700

102,600

88,600

106,200

137,000

171,600

104,100

120,200

Net proceeds from sale of business

182,500

5,200

154,600

69,100

0

0

-

8,600

Proceeds from sale of the Tysabri® financial asset

0

0

2,200,000

0

0

-

-

-

Other investing, net

-3,000

0

14,800

3,600

-1,800

8,800

0

-

Net cash from (for) investing activities

-596,100

-126,800

2,338,100

-175,000

-2,302,300

-1,644,300

-947,800

-684,100

Cash Flows From (For) Financing Activities
Issuances of long-term debt

600,000

431,000

0

1,190,300

2,504,300

3,293,600

637,300

1,089,200

Payments on long-term debt

476,000

482,500

2,611,000

559,200

1,823,500

2,035,000

40,000

610,000

Borrowings (repayments) of revolving credit agreements and other financing, net

500

-4,400

6,800

-802,500

-54,000

-3,000

5,000

-2,700

Premiums on early debt retirement

0

0

116,100

600

0

133,500

0

0

Deferred financing fees

1,000

2,400

4,800

2,800

28,100

48,800

6,000

5,100

Issuance of ordinary shares

900

1,300

700

8,300

1,043,500

9,800

10,700

11,600

Equity issuance costs

-

-

-

10,300

35,700

0

0

-

Excess tax benefit of stock transactions

-

-

-

-

-

-

-

12,900

Repurchase of ordinary shares

0

400,000

191,500

0

0

0

0

8,200

Cash dividends

112,400

104,900

91,100

83,200

64,800

46,100

33,000

29,000

Purchase of noncontrolling interest

-

-

-

-

-

-

-

0

Other financing, net

-10,200

-10,000

2,300

-8,700

-19,300

-9,000

3,300

-

Net cash from (for) financing activities

1,800

-571,900

-3,004,700

-268,700

1,522,400

1,028,000

577,200

458,700

Effect of exchange rate changes on cash and cash equivalents

9,700

-21,900

24,100

-6,700

-89,200

2,900

-5,800

4,400

Net increase (decrease) in cash and cash equivalents

-196,800

-127,600

56,400

204,500

-13,900

19,600

177,400

292,400

Supplemental Disclosures of Cash Flow Information
Cash paid/received during the year for:
Interest paid

136,800

133,800

187,600

205,100

143,200

98,400

58,500

53,700

Interest received

15,100

5,000

9,300

1,200

1,100

2,400

3,900

4,000

Income taxes paid

136,200

144,200

186,900

139,500

131,000

93,200

133,200

82,300

Income taxes refunded

28,000

5,100

3,600

9,300

9,600

4,300

1,300

900